Tuesday 11 June 2019

Risks to midcap rally | Top funds play contrarian | 178 stocks in risky zone

To keep you updated, we send ET Markets Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here

DAILY BRIEF

Tue, Jun 11, 2019

#ValueInvestor#SmallcapHunters#Paathshala#ExpertView#Podcast
TOP OF THE DAY
Tech View: Nifty50 forms Doji for third straight session, looks weak
The NSE Nifty50 has formed higher highs and lows for the second straight session.
This uninvited guest can crash midcap party on Dalal Street
Top fund houses wagered on many contra bets this May
178 stocks look set to tumble, suggests MACD
After Market: Jet, Indiabulls Housing tank; Adag stocks mixed
Hope rally on in market, pain will show post Budget, say analysts
Anil Ambani says group will repay all debt, delayed court awards hurting

Top Gainers

NSE
6 companies (largecap) appreciated more than 3%
Tata Motors (dvr) 4.36%
Aurobindo Pharm 3.99%
More from Gainers

Top Losers

NSE
1 company (largecap) price decreased more than -5%
Ibull HousingFin -8.02%
More from Losers

52 Week High

NSE
26 companies touched new 52-week high today
Nesco Ltd 5.98%
CreditAccess Grameen Ltd. 5.44%
More from 52 Week High
AdvertorialNegotiation strategies for women for a higher salary
AdvertorialUnderstanding the perks and woes of business travel
Moody's places Yes Bank's ratings under review for downgrade
Yes Bank had a 7 per cent direct exposure to the commercial and residential real estate sector.
F&O: Nifty50's trading range shifts to 11,750-12,250 zone
Goldman sees hard path to Opec+ extension for Russia, Saudis
3 reasons Ridham Desai's confident a new growth cycle has dawned
RECOMMENDATIONS
Bharti Airtel Ltd. Buy
Repco Home Finance Ltd. Hold
Mahanagar Gas Ltd. Reduce
Berger Paints (India) Ltd. Add
Carborundum Universal Ltd. Buy
Arun Thukral on 2 triggers that will change consumption cycle
Thukral is betting on private banks, IT, consumer and pharma in that order.
Deven Choksey is betting on these 2 value plays
It makes sense to avoid NBFCs and pharma despite corrections: Hemang Jani
Suzlon may default on Rs 1.2K crore FCCBs due July
Quick Links
Markets Live | Market Stats | IPOs | Technicals | Commodities | Forex
Follow Us:
Download ET Markets App:

No comments:

Post a Comment